CERITINIB IS EFFECTIVE IN ALK-REARRANGED NSCLC

被引：0
|
作者：
不详
机构：
来源：
CANCER DISCOVERY | 2014年 / 4卷 / 06期
关键词：
D O I：
10.1158/2159-8290.CD-RW2016-140
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：632 / 632
页数：1
相关论文
共 50 条
  • [31] Mechanisms of Acquired Resistance to the ALK Inhibitor Lorlatinib in ALK-Rearranged NSCLC Cell Lines
    Madsen, A.
    Jakobsen, K.
    Demuth, C.
    Sorensen, B.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2255 - S2255
  • [32] Ceritinib Efficacy and Safety in Treatment-Naive Asian Patients With Advanced ALK-Rearranged NSCLC: An ASCEND-4 Subgroup Analysis
    Tan, Daniel S. W.
    Geater, Sarayut
    Yu, Chong-Jen
    Tsai, Chun -Ming
    Hsia, Te-Chun
    Chen, Jun
    Lin, Meng-Chih
    Lu, You
    Sriuranpong, Virote
    Yang, Cheng-Ta
    Sen, Paramita
    Branle, Fabrice
    Shi, Michael
    Wu, Yi-Long
    JTO CLINICAL AND RESEARCH REPORTS, 2021, 2 (03):
  • [33] Identification and monitoring of a high-level MET amplification in CTCs and cfTNA in an ALK-rearranged NSCLC patient treated with crizotinib, alectinib and ceritinib
    Berger, L. A.
    Velthaus, J. L.
    Janning, M.
    Schatz, S.
    Falk, M.
    Iglauer, P.
    Simon, R.
    Cao, R.
    Bramlett, K.
    Buson, G.
    Petrini, E.
    Forcato, C.
    Tiemann, M.
    Sauter, G.
    Bokemeyer, C.
    Reck, M.
    Riethdorf, S.
    Pantel, K.
    Wikman, H.
    Loges, S.
    CLINICAL & EXPERIMENTAL METASTASIS, 2018, 35 (03) : 183 - 183
  • [34] SHP2 inhibition restores sensitivity to ALK inhibitors in resistant ALK-rearranged NSCLC
    Dardaei, Leila
    Wang, Hui Qin
    Singh, Manrose
    Fordjour, Paul
    Yoda, Satoshi
    Kerr, Grainne
    Liang, Jinsheng
    Cao, Yichen
    Chen, Yan
    Gainor, Justin
    Friboulet, Luc
    Dagogo-Jack, Ibiayi
    Myers, David
    Labrot, Emma
    Ruddy, David
    Parks, Melissa
    Lee, Dana
    DiCecca, Richard
    Moody, Susan
    Hao, Huaixiang
    Mohseni, Morvarid
    LaMarche, Matthew
    Williams, Juliet
    Hoffmaster, Keith
    Caponigro, Giordano
    Shaw, Alice
    Hata, Aaron
    Benes, Cyril
    Li, Fang
    Engelman, Jeffrey
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [35] Genetic landscape of patients with ALK-rearranged non-small-cell lung cancer (NSCLC) and response to ceritinib in ASCEND-1 study
    Tan, D. S-W.
    Thomas, M.
    Kim, D-W.
    Szpakowski, S.
    Urban, P.
    Mehra, R.
    Chow, L. Q. M.
    Sharma, S.
    Solomon, B. J.
    Felip, E.
    Camidge, D. R.
    Vansteenkiste, J.
    Petruzzelli, L.
    Pantano, S.
    Shaw, A. T.
    LUNG CANCER, 2022, 163 : 7 - 13
  • [36] A selective ALK inhibitor in ALK-rearranged patients
    Yang, James Chih-Hsin
    LANCET ONCOLOGY, 2013, 14 (07): : 564 - 565
  • [37] Real Clinical Practice in ALK-rearranged NSCLC Patients: A Retrospective Observational Study
    Okauchi, Shinichiro
    Numata, Takeshi
    Nawa, Takeshi
    Ichimura, Hideo
    Saito, Takefumi
    Hayashihara, Kenji
    Yamada, Hideyasu
    Satoh, Hiroaki
    Endo, Takeshi
    Inage, Yoshihisa
    Kaburagi, Takayuki
    Kiyoshima, Moriyuki
    Yamada, Yutaka
    Tamura, Tomohiro
    Saito, Kazuhito
    Inagaki, Masaharu
    Hizawa, Nobuyuki
    Sato, Yukio
    Shiozawa, Toshihiro
    Sekine, Ikuo
    Ishikawa, Hiroichi
    Kurihima, Koichi
    Sakai, Mitsuaki
    Kamiyama, Koichi
    Kimura, Masaki
    Kikuchi, Norihiro
    Nakamura, Hiroyuki
    Furukawa, Kinya
    Kodama, Takahide
    Miyazaki, Kunihiko
    Yamashita, Takaaki
    Hayashi, Shigen
    Funayama, Yasunori
    Nomura, Akihiro
    ANTICANCER RESEARCH, 2020, 40 (02) : 957 - 964
  • [38] Alectinib as first-line therapy for ALK-rearranged NSCLC: a no-brainer?
    Thai, A. A.
    Solomon, B. J.
    ANNALS OF ONCOLOGY, 2018, 29 (11) : 2160 - 2162
  • [39] A small-molecule degrader selectively inhibits the growth of ALK-rearranged lung cancer with ceritinib resistance
    Li, Xin
    Wang, Zixiong
    Chen, Chao
    Yang, Fan
    Liu, Ping
    Fang, Shu
    Wang, Bin
    Chen, Shi
    Li, Xinjian
    ISCIENCE, 2024, 27 (02)
  • [40] Treatment Algorithm for Advanced ALK-Rearranged NSCLC: A Marathon Rather Than a Sprint
    Zhou, Fei
    Zhou, Caicun
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (04) : 485 - 488
12345